# AVASTIN
> **BLA125085** · Biologics License Application · Sponsor: GENENTECH · Approved 2004-02-26
## Drug
- **FDA Application Number:** BLA125085
- **Application type:** Biologics License Application
- **Brand name:** AVASTIN
- **Generic name:** BEVACIZUMAB
- **Active ingredients:** BEVACIZUMAB
- **Dosage form:** VIAL
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2004-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125085)
---
*AI Analytics · CC0 1.0*